Expertise in
7
conditions

Shuichi Hironaka

Tokyo, JP 
Expertise in
7
conditions
Tokyo, JP 

Overview

Shuichi Hironaka practices practicing medicine in Tokyo, Japan.

Mr. Hironaka is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Esophageal Cancer, Gastroesophageal Junction Cancer, Colorectal Cancer, and Endoscopy.

He is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Tokyo, Japan
Other Locations
Mitaka, 1818611, Japan
Shinkawa, 1818611, Japan
Chuo, Japan
Saitama, Japan
Chiba, Japan
Hidaka, 3501298, Japan
Oita, Japan
Yufu, Japan
Shizuoka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3

95 Total Publications

Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.
Journal: Targeted oncology
Published: November 17, 2025

Frequently Asked Questions about Shuichi Hironaka

Is Shuichi Hironaka a top-rated expert for Stomach Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Shuichi Hironaka is classified as an Elite expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shuichi Hironaka participate in research or clinical trials?

Yes. Shuichi Hironaka has published 95 articles and abstracts on conditions like Stomach Cancer. You can view a list of Shuichi Hironaka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hironaka's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile